Zentalis Pharmaceuticals
ZNTL
ZNTL
116 hedge funds and large institutions have $2.71B invested in Zentalis Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 60 increasing their positions, 28 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
5.39% less ownership
Funds ownership: 96.96% → 91.57% (-5.4%)
17% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 18
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
116
Holding in Top 10
1
Calls
$28.8M
Puts
$434K
Top Buyers
| 1 | +$31.4M | |
| 2 | +$29M | |
| 3 | +$22.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.8M |
| 5 |
MCMC
Matrix Capital Management Company
Portsmouth,
New Hampshire
|
+$16.6M |
Top Sellers
| 1 | -$22.6M | |
| 2 | -$18.7M | |
| 3 | -$10.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.68M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$4.84M |